Mechanisms linking hypertriglyceridemia to acute pancreatitis
Acta Physiologica · 2023-03 · 237 (3)
DOI: 10.1111/apha.13916 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Physiologica, online erschienen am 13.01.2023. Verfasst von Lóránd Kiss und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Pancreatitis, Hypertriglyceridemia. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, Emberi Eroforrások Minisztériuma, Innovációs és Technológiai Minisztérium.
Abstract (Originalsprache)
Hypertriglyceridemia (HTG) is a metabolic disorder, defined when serum or plasma triglyceride concentration (seTG) is >1.7 mM. HTG can be categorized as mild to very severe groups based on the seTG value. The risk of acute pancreatitis (AP), a serious disease with high mortality and without specific therapy, increases with the degree of HTG. Furthermore, even mild or moderate HTG aggravates AP initiated by other important etiological factors, including alcohol or bile stone. This review briefly summarizes the pathophysiology of HTG, the epidemiology of HTG‐induced AP and the clinically observed effects of HTG on the outcomes of AP. Our main focus is to discuss the pathophysiological mechanisms linking HTG to AP. HTG is accompanied by an increased serum fatty acid (FA) concentration, and experimental results have demonstrated that these FAs have the most prominent role in causing the consequences of HTG during AP. FAs inhibit mitochondrial complexes in pancreatic acinar cells, induce pathological elevation of intracellular Ca 2+ concentration, cytokine release and tissue injury, and reduce the function of pancreatic ducts. Furthermore, high FA concentrations can induce respiratory, kidney, and cardiovascular failure in AP. All these effects may contribute to the observed increased AP severity and frequent organ failure in patients. Importantly, experimental results suggest that the reduction of FA production by lipase inhibitors can open up new therapeutic options of AP. Overall, investigating the pathophysiology of HTG‐induced AP or AP in the presence of HTG and determining possible treatments are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, University of Szeged, Szeged, Hungary.
- Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona, USA.
- Institute for Endocrinology, Diabetology and Metabolism, University Hospital Minden, Minden, Germany.
- Justus-Liebig-Universität Giessen, Giessen, Germany.
ORCID-Profile: Lóránd Kiss, Gabriella Fűr, Vijay Singh, Zoltán Rakonczay
Förderung
- U.S. Department of Defense
- Emberi Eroforrások Minisztériuma
- Innovációs és Technológiai Minisztérium
- Magyar Tudományos Akadémia
- European Regional Development Fund
- National Institute of Diabetes and Digestive and Kidney Diseases
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Zitieren
APA
Kiss, L., Fűr, G., Pisipati, S., Rajalingamgari, P., Ewald, N., Singh, V., & Rakonczay, Z. (2023). Mechanisms linking hypertriglyceridemia to acute pancreatitis. Acta Physiologica, 237(3). https://doi.org/10.1111/apha.13916
Vancouver
Kiss L, Fűr G, Pisipati S, Rajalingamgari P, Ewald N, Singh V, et al. Mechanisms linking hypertriglyceridemia to acute pancreatitis. Acta Physiologica. 2023;237(3). doi:10.1111/apha.13916
BibTeX
@article{Kiss2023,
author = {Kiss, Lóránd and Fűr, Gabriella and Pisipati, Sailaja and Rajalingamgari, Prasad and Ewald, Nils and Singh, Vijay and Rakonczay, Zoltán},
title = {Mechanisms linking hypertriglyceridemia to acute pancreatitis},
journal = {Acta Physiologica},
year = {2023},
volume = {237},
number = {3},
doi = {10.1111/apha.13916}
}
EUVIMED